Vaccine developer GreenLight Biosciences is going public through a $1.5 billion SPAC deal, according to a new report by The Wall Street Journal. "This is a company we believe will be ...

SK bioscience has received the green light from an Indonesian regulator to export its self-developed influenza vaccine, the ...

Indonesia's influenza vaccine market is projected to grow to $69.1 million in 2030 from 2022’s $38.5 million, according to market researcher Innsight10. SKYCellflu is the world's first cell ...